ARKG250117P29500
- 0.00
- 0.000.00%
ARK Genomic Revolution ETF Newsroom
Natera Shares Are Trading Higher After JP Morgan Upgraded the Stock From Underweight to Neutral and Raised Its Price Target From $40 to $50.
Natera Shares Are Trading Higher After the Company Reported Preliminary FY24 Financial Results.
Guardant Health Announced Preliminary FY2024 Sales Of Approximately $737M, An Increase Of 31% Compared To Consensus Of $723.9M
CareDx Expects Q4 Revenue Of $85M-$86M Vs $82.16M Est, FY24 Revenue Of $332M-$333M Vs $329.4M Est, FY25 Revenue Of $370M Vs $366.7M Est
Natera Guides Q4 and FY Revenue Above Consensus
Plug Power, Capri And Frontline Are Among Top Mid Cap Gainers Last Week (Jan 6-10): Are The Others In Your Portfolio?
Can 2025 J.P. Morgan Healthcare Conference Spark Biotech M&A?
Cathie Wood's Ark Invest Loads Up On Intellia Therapeutics Which Laid Off Over A Quarter Of Its Workforce
The Analyst Verdict: Natera In The Eyes Of 14 Experts
Gene Editing Stocks Drop as Intellia Announces Layoffs
Recursion Pharmaceuticals Analyst Ratings
Cathie Wood Sells 36K Shares of Her Own Bitcoin Backed ARKB to Start off 2025
Beam Upgraded by Bernstein Ahead of AATD Data
Recursion Pharmaceuticals Announces 2 Key Investigational Oncology Drugs Advancing To Clinical Trials, Targeting High Unmet Needs In Hematologic Malignancies, Small-Cell Lung Cancer, & More
The "magic of the profit-making effect" is frequently appearing! NVIDIA's latest investment blueprint has been released, and these 13 companies are expected to take off.
Apart from NVIDIA itself, the key tracks and companies it invests in and pays attention to are also frequently favored by the U.S. stock market. The market believes that NVIDIA's investments often represent the development direction of the Industry, reflect the key areas of AI technology applications, and hint at potential technological breakthroughs.
Cathie Wood's Ark Invest Books Profits On Hot AI Stock Palantir, Sells Bitcoin ETF Shares As BTC Starts 2025 On A Positive Note
Natera Shares Are Trading Higher After Canaccord Genuity Raised Its Price Target on the Stock From $165 to $180.
Nio, Unity Software And Other Big Stocks Moving Higher On Thursday
Mizuho CEO Sees Global Boom in M&A After Trump Takes Office
SA Asks: Which Big Pharmas Are Likely to Announce Big M&A Deals?